Oxidative stress is considered a cause or propagator of acute and chronic d
isorders of the central nervous system. Novel 2,4-diamino-pyrrolo[2,3-d]pyr
imidines are potent inhibitors of iron-dependent lipid peroxidation, are cy
toprotective in cell culture models of oxidative injury, and are neuroprote
ctive in brain injury and ischemia models. The selection of lead candidates
from this series required that they reach target cells deep within brain t
issue in efficacious amounts after oral dosing. A homologous series of 26 h
ighly lipophilic pyrrolopyrimidines was examined using cultured cell monola
yers to understand the structure-permeability relationship and to use this
information to predict brain penetration and residence time. Pyrrolopyrimid
ines were shown to be a more permeable structural class of membrane-interac
tive antioxidants where transepithelial permeability was inversely related
to lipophilicity or to cell partitioning. Pyrrole substitutions influence c
ell partitioning where bulky hydrophobic groups increased partitioning and
decreased permeability and smaller hydrophobic groups and more hydrophilic
groups, especially those capable of weak hydrogen bonding, decreased partit
ioning, and increased permeability. Transmonolayer diffusion for these memb
rane-inter active antioxidants was limited mostly by desorption from the re
ceiver-side membrane into the buffer. Thus, in this case, these in vitro ce
ll monolayer models do not adequately mimic the in vivo situation by undere
stimating in vivo bioavailability of highly lipophilic compounds unless acc
epters, such as serum proteins, are added to the receiving buffer.